Immunochemotherapy of mice S-180 ascitic tumor by combination of cyclophosphamide and BCG
Chiou, C.Y.; Wong, Y.H.
Gaoxiong Yi Xue Ke Xue Za Zhi 2(3): 164-171
1986
ISSN/ISBN: 0257-5655 PMID: 3482884 Document Number: 273006
Document emailed within 1 workday
Related Documents
Sarna, S.; Bhola, R.K. 1989: Adoptive immunotherapy of tumor in mice in combination with cyclophosphamide Archivum Immunologiae et Therapiae Experimentalis 37(5-6): 533-538Crispens, C.G.; Sorenson, J.R. 1990: Combination therapy with CuDIPS, Tween 80 and cyclophosphamide: effects on survival and tumor incidence in SJL/J mice In Vivo 4(5): 321-323
Nowak, C.; Arnold, W.; Henneberger, G.; Tanneberger, S. 1980: Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems Archiv für Geschwulstforschung 50(8): 747-757
Fisher, B.; Gunduz, N. 1979: Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice Journal of the National Cancer Institute 62(6): 1545-1551
Bogomolova, N.S.; Chernov, V.A. 1972: Action of prospidine on respiration and glycolysis of tumor cells in ascitic Ehrlich cancer in mice Farmakologiia i Toksikologiia 35(3): 339-342
Lubiniecki, A.S.; Cypess, R.H. 1975: Quantitative study of the effect of previous Trichinella spiralis infection on sarcoma 180 ascitic tumor formation in mice Tropenmedizin und Parasitologie 26(3): 329-334
Voelcker, G.; Jaschke, A.; Wrabetz, E.; Hohorst, H.J. 1984: Intracavitary chemotherapy of S 180 ascites sarcoma in mice with 4-(S-ethanol)-sulfido-cyclophosphamide in combination with protector thiols Arzneimittel-Forschung 34(10): 1291-1298
Wang, B.-b.; Wang, X.-h.; Liu, K.; Sun, S.-b.; Song, P.; Li, Y.-d. 2015: Enhanced radiosensitivity of H22 ascitic tumor to 12C6+ ions radiation in ultra-filtration extract mixture from Astragalus mongholicus-treated mice Yao Xue Xue Bao 50(12): 1596-1602
Nielsen, L.L.; Gurnani, M.; Catino, J.J.; Tyler, R.D. 1995: In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic background Anticancer Research 15(2): 385-392
Pauluzzi, S.; Merletti, L. 1977: Effect of cyclophosphamide on syngeneic transplantation of adenovirus 12-transformed tumor cells in C3H/he mice Bollettino dell'Istituto Sieroterapico Milanese 56(4): 310-315
Tashiro, K.; Kondo, N.; Ikemoto, I. 1986: A case of complete remission of distant metastases of a renal pelvic tumor by combination chemotherapy with mitomycin, cyclophosphamide and 5-fluorouracil Hinyokika Kiyo. Acta Urologica Japonica 32(3): 449-453
Marconi, P.; Cassone, A.; Baccarini, M.; Tissi, L.; Garaci, E.; Bonmassar, E.; Frati, L.; Bistoni, F. 1983: Relationships among tumor load, route of tumor inoculation, and response to immunochemotherapy in a murine lymphoma model Journal of the National Cancer Institute 71(2): 299-307
Huang, H.; Lian, L.; Huang, R. 1995: Response of ovarian endodermal sinus tumor to combination chemotherapy with cis-platinum, vincristine and bleomycin or vincristine, actinomycin and cyclophosphamide Zhonghua Fu Chan Ke Za Zhi 30(5): 265-269
Itashiki, Y.; Harada, K.; Ferdous, T.; Yoshida, H. 2007: Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice Anticancer Research 27(4b): 2365-2375
Yin, D.; Zhang, X.; Feng, Y. 1996: Effects of recombinant human tumor necrosis factor on the development of ascitic tumor and expression of c-erbB2 in the nude mouse models of ovarian cancer Zhonghua Fu Chan Ke Za Zhi 31(5): 291-292
Yamamoto, M.; Fujii, H. 1995: Optimal locoregional immunochemotherapy after tumor-mass reduction for advanced hepatocellular carcinoma Hepato-Gastroenterology 42(5): 567-577
Sukegawa, Y.; Kawamura, J.; Okuno, K. 2017: Survival Benefit by Combined Administration of Cyclophosphamide, Lentinula edodes Mycelia Extract(LEM), and Ganoderma lucidum Mycelia Extract(MAK)in S1018B10 Tumor-Bearing Mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(10): 896-899
Futami, H.; Jansen, R.; MacPhee, M.J.; Keller, J.; McCormick, K.; Longo, D.L.; Oppenheim, J.J.; Ruscetti, F.W.; Wiltrout, R.H. 1990: Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy Journal of Immunology 145(12): 4121-4130
Uzuka, Y.; Saito, Y.; Takahashi, H.; Komatsu, M.; Ito, T. 1989: Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2269-2273
Fomina, M.M.; Minenkova, E.A.; Lankin, V.Z.; Poroshenko, G.G.; Evseenko, L.S. 1979: Polymorphism of a tumor cell population and selective processes. III. a change in the correlation of tumor cell subpopulations of the ascitic strain of Ehrlich-I.Ch.Ph. under the influence of glucose and sodium succinate Tsitologiia 21(8): 953-958